Corporate Partners

Thank you to our ISCT 2023 Corporate Partners

DIAMOND SPONSORS

At Cytiva, we believe the key to transforming human health is accessing life-changing therapies. That's why our 10,000+ associates in more than 40 countries are keenly focused on helping researchers, biopharma companies, and drug manufacturers to advance and accelerate therapeutics for people that need them.

Learn more at cytiva.com


Visit Website
MaxCyte® is a leading provider of cell-engineering platform technologies and is responsible for helping to bring next‐generation cell-based therapies to life. The Company's technology is employed by leading drug developers worldwide, including 20 of the top 25 global biopharmaceutical companies. Our Flow Electroporation® technology and next-generation ExPERT™ platform enable our partners to accelerate, streamline, and improve the drug development process from the early stages of research to commercialization. Founded in 1998, MaxCyte is headquartered in Gaithersburg, Maryland, U.S.


Visit Website
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.


Visit Website
Sony Biotechnology Inc. is dedicated to helping the scientific community of researchers, laboratory professionals, and institutions achieve the best scientific results possible. By leveraging Sony’s comprehensive expertise in electronics innovation and design and with our technological assets we are accelerating development of next-generation cell analysis systems. We bring a unique perspective to science’s high-level instrumentation and are creating innovative products to address our customer’s challenges.


Visit Website
T-BCT-Stack-RGB-2400px.png
Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today.


Visit Website
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry. Our platform includes GRex® cell culture technology, the Lovo and Cue cell processing systems, and a wide range of GMP proteins, reagents, media, and gene editing technologies.


Visit Website

PLATINUM SPONSORS

A global leader in in-vitro diagnostics for over 55 years, bioMérieux has always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide. The Company is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. It provides diagnostic solutions that improve patient health and ensure consumer safety. At bioMérieux, we are proud to have a long history in the field of industrial microbiology. Cutting-edge cell and gene therapy products demand state-of-the-art quality control. With a comprehensive portfolio of rapid microbiology testing solutions, bioMérieux can help streamline workflows, boost efficiency, prevent compliance issues and ensure patient safety.


Visit Website
Roche CustomBiotech - We provide reliable, tailor-made and high-quality raw materials, kits and technologies to biopharma and diagnostics companies.

Roche CustomBiotech enables the healthcare industry in bringing state-of-the-art diagnostics and treatments to those in need. With the CustomBiotech division Roche merged its innovative technologies, excellent knowledge, and decades of experience in the Biopharma and Diagnostics Industry. The site in Penzberg, Germany, is Roche´s powerhouse of manufacturing and its excellence in manufacturing enables companies in Biopharma or Diagnostics to get access to tailored solutions meeting the highest standards in quality, safety and regulatory requirements, from ISO-certified quality management to GMP, animal-free and antibiotic-free production of excipients, raw materials, kits and innovative instruments. The products from Roche CustomBiotech are off the shelf or customizable to meet excellent quality and regulatory needs. Quality, Innovation and the individual customer interest are in the center of the Roche CustomBiotech´s business, pathing the way for an ever expanding product portfolio meeting the current interests and needs of our customers and thereby enabling innovative drugs and products.


Visit Website
Driven by science and a passion for quality, STEMCELL Technologies offers over 2500 tools and services to support discoveries in fields such as regenerative medicine, immunotherapy, and disease research. Whether you're culturing and editing hematopoietic stem and progenitor cells, differentiating pluripotent stem cells, or activating and expanding immune cells, we have the specialized cell isolation products, high-performance cell culture media, and accessory tools for your research. By increasing the accessibility of innovative techniques like gene editing and organoid cultures, we’re helping scientists accelerate the pace of discovery—so they can get therapies to patients faster. Researchers in need of high-compliance products can also obtain guidance and customized support through our Services for Cell Therapy Program on how to qualify our products for use as raw/ancillary materials. To learn more, visit www.STEMCELL.com.


Visit Website
As the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support need to accelerate the pace of cell and gene therapy development. We understand the complexity of this rapidly-evolving industry and have made significant investments in cGMP raw material manufacturing and drug product manufacturing capabilities to provide innovative workflow solutions. Partner with us to access the high-quality materials, services, and support you need from discovery to clinical research and commercial cell and gene manufacturing. Through our Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab services, Patheon, and Gibco brands, we offer an unmatched combination of innovative technologies, manufacturing, and distribution capabilities.


Visit Website

GOLD SPONSORS

Akron Bio drives advanced therapy development and commercialization with high-quality, industrial-scale solutions. Akron’s strategic focus is supplying cGMP-compliant ancillary materials and services to enable the advancement of cell and gene therapies. These include cytokines and growth factors, human sera and purified proteins, plasmid DNA manufacturing, and custom development services. Akron supports clients with rigorous documentation and quality standards to fulfill their regulatory demands. Our unique capabilities allow us to seamlessly transition from R&D to preclinical and clinical and drive the emerging regenerative medicine sector to unmet clinical needs through affordable and seamless manufacturing options.


Visit Website

ASEPTIC TECHNOLOGIES develops, manufactures and markets innovative aseptic solution for the BioPharmaceutical industry.

Its equipment and devices are designed to provide safer & easier operations for aseptic fill and finish, the best-known being the AT-Closed Vial® technology.

The AT-Closed Vial® is manufactured in ISO 5 clean room with the stopper secured in place and gamma sterilized. Vial size ranges from 1 to 50ml. The filling of these ready-to-use vials is performed by a special needle piercing the stopper and dispensing the drug product. The stopper is then immediately resealed by a laser and a cap is snap-fitted on it. Various equipment offer an easy scale-up from manual to fully automated operation.

The benefits of the technology are: better sterility assurance, reduced investments, increased safety during whole supply chain, strong operating cost reduction.

The AT-Closed Vial® technology is widely used in the Cell and Gene Therapies as it offers uncompromised container closure integrity even during storage at cryogenic temperature.


Visit Website

Azenta Life Sciences provides unrivaled sample exploration and management solutions to help our customers accelerate discovery, development, and delivery to bring impactful breakthroughs and therapies to market faster. We are the global leader in automated compound management for drug discovery, biological storage, and sample processing solutions. Azenta understands the importance of sample integrity and provides a comprehensive range of solutions across our leading capabilities of genomic services, sample repository services (SRS), consumables and instruments, data management and informatics, sample sourcing, and automated ultra-cold storage.


Visit Website

Established in 2019, BioCentriq is a full-service, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing. It was purchased by GC of South Korea for $73M in May 2022. With over 50 scientists, engineers, analysts, and manufacturing specialists, the company has established quality systems and the infrastructure required to support the release of both autologous and allogeneic drug products. BioCentriq also specializes in viral vector process development and manufacturing and has expertise in a variety of cell and vector types. Their 25,000 square feet of facilities includes four ISO-7 certified GMP manufacturing suites, a fully equipped process development laboratory, quality control and analytical method development laboratories, and training facilities. It is also home to the only McKinsey-owned Digital Capability Center designed to explore the application of industry 4.0, digital and lean manufacturing disciplines to life sciences. For more information, visit BioCentriq.com.


Visit Website

XBiotech and BioBridge Global Collaborate on FDA Program to

About BioBridge Global: BioBridge Global (BBG) is a San Antonio, Texas-based 501(c)(3) nonprofit corporation that offers diverse services through its subsidiaries – the South Texas Blood & Tissue Center, QualTex Laboratories, GenCure and the Blood & Tissue Center Foundation. BBG provides products and services in blood resource management, cellular therapy, donated umbilical cord blood and human tissue as well as testing of blood, plasma and tissue products for clients in the United States and worldwide. BBG is committed to saving and enhancing lives through the healing power of human cells and tissue. It enables advances in the field of regenerative medicine by providing access to human cells and tissue, testing services, and biomanufacturing and clinical trials support. Learn more at BioBridgeGlobal.org.

Visit Website
BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Our portfolio includes our proprietary CryoStor® freeze media and HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, Custom Biogenic Systems® high-capacity cryogenic storage freezers, SciSafe biologic materials storage, Stirling Ultracold ULT freezers, and Sexton Biotechnologies cell processing tools. For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com and www.sextonbio.com and follow BioLife on Twitter.


Visit Website
Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies that are more affordable and widely available to patients in need. With Cellares’s proprietary platform—the Cell Shuttle—biopharma companies, academic research centers, and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale. The company is headquartered in South San Francisco, CA.


Visit Website

At Lonza Cell & Gene Technologies, we provide contract development and manufacturing services that enable pharma and biotech companies to realize life-changing cell & gene therapies for their patients. From the building blocks of life to the delivery of your therapy to patients, our solutions are created to simplify your outsourcing experience and provide a reliable outcome when you expect it. Our unmatched expertise in process development, paired with our standardized, systematic approach to cGMP manufacturing have already demonstrated our ability and capabilities to successfully take cell & gene therapies to commercialization time and time again. We continuously invest to solve not just the current, but also the future challenges. Together, let’s realize your life-changing therapy.


Visit Website

FUJIFILM Irvine Scientific supports cell and gene therapy manufacturers with over 50 years of cell culture media knowledge and expertise. Our products advance the development of processes and workflows, to help users obtain optimal performance and safety of their final manufactured cells. We deliver high-performance media and expert support that can directly influence advanced cell and gene therapies. By providing innovative, first-to-market products and workflow solutions, we holistically drive and accelerate user efforts with complete media solutions for basic, translational, and clinical research, as well as commercial applications.


Visit Website
Mayo Clinic's Center for Regenerative Biotherapeutics seeks to integrate, develop and deploy new regenerative medicine products and services that continually differentiate Mayo's practice to draw patients from around the world for complex care.


Visit Website

OmniaBio Inc. is a contract development and manufacturing organization (CDMO) focused on cell and gene therapies from pre-clinical through to commercialization, and a subsidiary of CCRM. Benefitting from CCRM’s existing expertise, OmniaBio provides a continuum of advanced process and analytical development, and manufacturing capabilities, by enabling focused support for clients from early clinical phase to commercial supply needs. OmniaBio is built upon leadership in iPSCs, immunotherapy and LVVs. To be located at McMaster Innovation Park, less than one hour from the U.S. border, OmniaBio’s new commercial manufacturing site will anchor a biomanufacturing centre of excellence and will open with late clinical phase and commercial capacity in 2024 in a site totalling approximately 100,000 square feet. OmniaBio is supported by the Government of Ontario, via the Invest Ontario Fund. Please visit us at www.omniabio.com.




Visit Website

SUPPORTERS

Accellix aims to bring the power of flow cytometry to the GMP manufacturing floor, automating the entire GMP cell phenotyping process from sample preparation to data analysis with the Accellix platform. We bring automated sample preparation, flow cytometry and data analysis into the cell therapy GMP manufacturing suite.
Our team is an interdisciplinary group composed of skilled biologists, engineers, mathematicians, technicians and more with deep experience in all aspects of the immunotherapy field and platform. Accellix has growing offices in Jerusalem, Israel and San Jose, CA.


Visit Website

ACROBiosystems|Tokyo Future Style, Inc.

ACROBiosystems is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. They offer a wide array of life sciences tools, reagents, and instruments to serve customers spanning over 7000 pharmaceuticals, CRO/CDMO, research institutions, and hospitals across 70 countries.



Visit Website

Home // AdvaBio

ADVA Biotechnology is an Israel-based private company located in Bar-Lev High-Tech Park, in northern Israel. ADVA Biotechnology was established in 2016 with the vision of "Valuing life by granting advanced therapies to patients".

Visit Website

Advent Bioservices is a CDMO that develops and manufactures cell therapies in a state-of-the-art facility in Cambridgeshire, England. We offer a wide range of services, including R&D, process development, quality control, and manufacturing, and we are committed to providing our clients with the highest quality products and services.
We have a team of experienced professionals with a proven track record in developing and manufacturing cell therapies. Our facilities are fully GMP compliant, and we operate under a comprehensive IT infrastructure. We also offer a variety of ancillary services, including technical support, process development, and QC.
Our mission is to provide our clients with reliable, flexible, and accommodating expert services. We work collaboratively with our clients to ensure that all needs are met so our clients can be confident that their final product will be safe, compliant, and of the highest quality.




Visit Website

Aenitis develop and promote devices for continuous, contactless and pressureless cells handling, using acoustic forces. Aenitis focus on cell and gene therapy players' challenges by developing innovative cost-effective bioprocessing systems for cell sorting, cell washing, cell confinement and cell isolation.


Visit Website
Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients rely on Aldevron-produced plasmid DNA, RNA, gene editing enzymes and more for projects ranging from discovery research to clinical trials to commercial applications. These efforts help accelerate development of treatments for diseases such as cancer, infectious disease, pediatric disorders and rare diseases.

Aldevron specializes in cGMP manufacturing and is known for inventing the GMP-Source® quality system. Aldevron operates the world’s largest cGMP plasmid DNA manufacturing facility, located at company headquarters in Fargo, North Dakota, with additional production facilities in Madison, Wisconsin, and Lincoln, Nebraska.



Visit Website

High Quality Human Primary Cells and Whole Tissue Products | AllCells®

Founded in 1998, AllCells, a Discovery Life Sciences company, is a market-leading provider of highly characterized primary cell and tissue products, supporting global biomedical organizations seeking to develop and manufacture novel drugs and cell therapies. By providing Clinical Grade and RUO products, custom donor management services, and integrated analytical capabilities, AllCells' comprehensive solutions streamline every stage of development to help bring novel therapies to market faster. Our FDA-registered, IRB-approved, AABB-compliant donor facilities strategically located across the U.S. provide access to healthy, recallable, well-characterized donors with diverse and rare demographics. Our adjacently located processing facilities enable immediate processing, cryopreservation, and a high degree of responsiveness to accommodate custom requests with exceptional quality and deliverability. Backed by over 30 years of combined scientific and regulatory expertise, AllCells is committed to providing flexible and scalable solutions necessary to dynamic, client-specific needs and timelines from inception to commercialization. AllCells – Science at your Service™




Visit Website

AMSBIO is contributing to the acceleration of discovery through the provision of cutting-edge life science products and services for R&D. We are able to provide solutions for studying cell motility, migration, invasion and proliferation. We also offer solutions for organoid and spheroid culture, regenerative medicine and stem cell research.


Visit Website

ANEMOCYTE | Talent for Life - Advanced Therapies

Anemocyte, a BMO based in Italy, offers development and manufacturing services from R&D to GMP to address needs of: pDNA - Plasmids for Viral Vector and RNA manufacturing; mRNA - mRNA manufacturing.



Visit Website

Arvato offers a fully integrated order-2-cash business model for both, healthcare providers and manufactures of Cell & Gene therapies. We manage the complexity of our client’s supply chains on a global scale. Our clients benefit from seamlessly integrated order-2-cash solutions with a dedicated focus on Cell & Gene therapies:
• Orchestration Platform & Integrations
• Case Management & Customer Services
• Temperature Controlled Warehousing at 18 international sites
• Postponement Services
• Transport Management
• Financial Services
• GMP + GDP Certified

Arvato integrates healthcare know-how, industry knowledge and broad understanding of processes and IT systems to develop bespoke outsourcing solutions. We connect our clients to the point of care, bringing them closer to their patients.


Visit Website

AstraZeneca - Research-Based BioPharmaceutical Company

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide




Visit Website

ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.



Visit Website

Avectas Limited - ByrneWallace LLP

Avectas is accelerating the future of cell therapy with a flexible, easy-to-integrate delivery platform that manufactures healthier and more functional cells for patients. Excelling at complex editing and challenging cargo delivery, the Avectas non-viral delivery platform ensures the next generation of cell therapies can be realized.
The Solupore non-viral delivery system enables the next generation of cell therapies through unparalleled cell health and superior cell functionality, expanding the possibilities for complex editing and challenging cargo delivery. Easy to integrate into existing GMP processes, Solupore accelerates the translation of life-saving therapies to patients.


Visit Website

AventaCell BioMedical Corp. ("AventaCell") is among the world leaders devoted to developing novel human-derived products for use in cell culture and tissue regeneration. Helios Bioscience is AventaCell's product family brand for their products to be used in cell culture and tissue regeneration. AventaCell technologies used in the Helios Bioscience line offer new human-derived solutions for use in translational research of cell and tissue-based therapies to meet the need for animal serum-free cell expansion and production. The demand for safe, efficient and cost-effective cell expansion and production is rapidly increasing with the growth in cell therapy and regenerative medicine research and clinical development. Helios Bioscience products are designed to support expansion and production of a broad range of cells including mesenchymal stem cells and multiple immunocell lines. AventaCell is committed to providing animal serum-free products to accelerate the research, development and commercialization of safe and efficacious cell and tissue-based therapeutics.



Visit Website

CytoSMART Technologies Joins the Axion BioSystems Brand | Business Wire

Looking for an immunotherapy potency assay that can save time, cut costs, and simplify your workflow? Accelerate your pipeline with Axion BioSystems’ live-cell assays. Using advanced electronics or imaging to noninvasively measure real-time biological responses, Axion’s suite of products can streamline your process. Straightforward and easy to use, track in vitro immune cell-mediated killing in a variety of plate formats. Assay on timescales from microseconds to months with no external labels or dyes. Gain unprecedented access to kinetic responses with exquisite sensitivity. Efficiently move potency assays from development to QC with GMP compliance available.




Visit Website

Barkey is a German family business for medical technology in the field of warming devices. Founded in 1980 by Volker Barkey, Thomas (CFO) and Christian Barkey (CEO) together with Armin Nowack (COO) and the entire staff have led the company to worldwide awareness in the hospital and blood bank sector as well as in cell & gene therapy research. Barkey’s two main goals: Preventing hypothermia and advancing Cell & Gene research to develop cancer therapies. Therefore, Barkey produces solutions for warming or thawing blood products, cellular materials, infusion solutions, etc. The safety of samples, user and, of course, patients is of priority. Barkey relies exclusively on dry heating systems since the use of open water baths offers a high risk of contamination. This must be avoided both, during the preparation of patient treatment and during the research and production of new therapeutic procedures. Barkey is part of the Azenta Group. The company is headquartered in Leopoldshoehe, NRW. Two subsidiaries in Boston, MA, US and Shanghai, CN as well as an extensive distributor network enable the worldwide availability of the TÜV and FDA certified products.


Visit Website

BD Biosciences - LIMINA

BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare.



Visit Website

BioCanRx is Canada’s Immunotherapy Network. Our vision is to turn all cancers into curable diseases. We are a network of scientists, clinicians, cancer stakeholders, academic institutions, NGOs and industry partners working together to accelerate the development of leading-edge immune oncology therapies for the benefit of patients. As a leader in the translation, manufacture and adoption of cancer immunotherapies, we invest in translating world-class technologies from the research lab into clinical trials. BioCanRx provides researchers with access to funding, expertise, training and biomanufacturing facilities. We train and develop the talent needed for a thriving Canadian health biotechnology sector. BioCanRx receives funding from the federal government’s Networks of Centres of Excellence, and support from industry, the provinces and charities. The network is hosted by the Ottawa Hospital Research Institute. https://biocanrx.com


Visit Website

BioInVision - Crunchbase Company Profile & Funding

BioInVision offers imaging instrumentation and and contract research services critical to preclinical studies. The unique CryoViz instrument, utilizing the patented cryo-imaging technology, combines microscopical anatomical and molecular fluorescence imaging of laboratory small animals or excised organs with single-cell sensitivity. The ultra-high resolution cryo-imaging allows detection of even single stem or cancer cells anywhere in a mouse reducing the gap between in vivo imaging and pathology. Powered by BioInVision’s Digital Microtome, fully automated unattended scans, multi-modal imaging framework, and 3D reconstruction software, CryoViz cryo-imaging is enabling discoveries in stem cell biodistribution, cancer metastatis, imaging agents, drug discovery, tissue engineering, phenotyping, and gene expression. BioInVision has an active research group and also develops custom software solutions for clinical applications.



Visit Website

Biospecimens and Research Services | BioIVT

With our high production capabilities and robust QC and QA processes, BioIVT is your trusted partner for hepatocytes, NPCs & subcellular fractions. Our contract research services capabilities and expert consulting team enable you to accelerate your ADME programs and develop comprehensive ADME strategies designed to accomplish your R&D goals. 




Visit Website

BioLamina AB is a Swedish biotechnology company built on a scientific foundation with a legacy in matrix biology and cell culture-based research. Our flagship products, our biorelevant human recombinant laminin isoforms, Biolaminin®, are defined cell culture matrices that successfully imitate the natural, cell-specific cell-matrix interaction in the cell culture dish, allowing the cells to thrive and maintain their function. Our products are a powerful resource for scientists working with stem cells and primary cells both within basic research as well as in regenerative medicine companies with a focus on cell therapy applications.


Visit Website
At BioLegend we know that to make a difference for all, we need to make a difference with our products. Our scientists are proud to create world-class, cutting-edge antibodies and reagents across a diverse set of research areas—from immunology and cancer research to neuroscience and stem cells. Founded by scientists for scientists, we aren’t just making a difference, we are different. We’re accelerating research and discovery by providing high-quality, purpose-driven products at an outstanding value. With over 28,000 trusted reagents, 80,000+ citations in peer-reviewed publications, and a dedicated team to create custom solutions for you, there’s nothing our expertise doesn’t cover. Discover the BioLegend difference to see how we can make an impact in your lab and beyond. Learn more at Biolegend.com




Visit Website

For over 30 years, Bionique Testing Laboratories continues to be a trusted partner and global leader in Mycoplasma Testing Services for the life science industry. We offer the full range of testing services from relevant compendia (USP <63> Mycoplasma Test) to a GMP compliant Real-Time PCR assay to support the development and clinical manufacturing of cell & gene therapies. From discovery to commercialization, our capabilities extend to method development and validation of rapid microbial methods to meet global regulatory requirements. Bionique delivers testing services that meet the highest quality standards and offers the fastest turnaround times in the industry.


Visit Website
Bio-ReCell is a cell therapy research and development company that has developed the first closed and automated system for target cell separation and isolation that yields pure and viable cells. The Bio-ReCell System uses a proprietary antibody-based technology that does not use magnetic particles and produces cell eluates with no contaminants such as residual antibodies, chemicals, and particles. Cell isolation is performed in sterile, biocompatible, and closed-loop cartridges that are cell-type specific in under 30 minutes. The technology is scalable from single patient use to large-scale GMP manufacturing processes. We have developed several cartridges, primarily targeting mesenchymal stem cells for autologous transplantation and T-cells for CAR-T therapies. We are seeking commercial and research partnerships in the field of cell and gene manufacturing and novel clinical application development with clinical trials.


Visit Website
BioSharing is a Network of eight FDA licensed blood centers that have formed a corporation to provide seamless scale-up of donor derived source materials, such as GMP leukopaks, bone marrow and cord blood. With decades of experience recruiting and collecting donors, the network is uniquely positioned to supply both small and large scale quantities of source material.


Visit Website
Bio-Techne unites the best in class life science brands, R&D Systems®, Novus Biologicals®, Tocris Bioscience®, ProteinSimple® and Advanced Cell Diagnostics. Our brands deliver a range of high quality and innovative tools, including proteins, small molecules and antibodies to meet the demands of the cell therapy market.
Bio-Techne also provides an expansive selection of next-generation protein analysis platforms, immunoassays and diagnostic technologies tailored for the cell therapy manufacturing process.

Bio-Techne strives to deliver the best cell therapy manufacturing experience for our customers, through our extensive product quality control and custom manufacturing services.



Visit Website
Bluechiip understands that every sample is critical. Our objective is to manage each one with optimal quality in the most efficient way. Bluechiip’s advanced sample management solution (readers, enabled samples and software) is the only system providing sample temperature with ID in cryogenic environments delivering confidence in every sample.


Visit Website

Leading Global CDMO for Pharma & Biotech | Catalent

Catalent Biologics has deep experience in development, manufacturing, and analytical services for new biological entities, biosimilars, plasmids DNA, cell and gene therapies, vaccines, sterile injectables, mRNA, and antibody-drug conjugates. Catalent has developed 680+ proteins and 16 marketed products using GPEx® technology, manufactured 45+ commercially-approved biotherapeutics, and supported 100+ clinical and commercial cell and gene therapy programs.
With customized solutions, Catalent can scale your program from development to commercial supply, bringing better treatments to patients, faster.
Capabilities include:
• GPEx® cell line development
• SMARTag® bioconjugation
• Expertise in plasmid DNA, viral vector, iPSC, and cell therapy manufacturing
• State-of-the-art biomanufacturing
• Comprehensive analytical services
• Award-winning fill/finish and packaging




Visit Website

CCRM Enters Regenerative Medicine Partnerships — OBIO ...

Catalent Biologics has deep experience in development, manufacturing, and analytical services for new biological entities, biosimilars, plasmids DNA, cell and gene therapies, vaccines, sterile injectables, mRNA, and antibody-drug conjugates. Catalent has developed 680+ proteins and 16 marketed products using GPEx® technology, manufactured 45+ commercially-approved biotherapeutics, and supported 100+ clinical and commercial cell and gene therapy programs.
With customized solutions, Catalent can scale your program from development to commercial supply, bringing better treatments to patients, faster.
Capabilities include:
• GPEx® cell line development
• SMARTag® bioconjugation
• Expertise in plasmid DNA, viral vector, iPSC, and cell therapy manufacturing
• State-of-the-art biomanufacturing
• Comprehensive analytical services
• Award-winning fill/finish and packaging


Visit Website

The Cell and Gene Therapy Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies with a vision of a thriving industry delivering life changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector. With over 400 experts covering all aspects of advanced therapies, it applies its unique capabilities and assets, collaborates with academia, industry and healthcare providers to develop new technology and innovation. The Cell and Gene Therapy Catapult works with Innovate UK. For more information, please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.

Visit Website

Cellcolabs is a biotech impact start-up specializing in industrial GMP production of high-quality Mesenchymal Stromal Cells (MSC), in order to make them available at scale.

We have seen first-hand how patients who could have been significantly helped by MSC, could not receive treatment due to unavailability and unaffordability. Therefore, founded in the Swedish capital Stockholm in 2021, we have industrialized the know-how at Karolinska Institute to make high-quality GMP produced MSCs available at scale to an affordable price. Our mission is by accelerating stem cell research, making the treatments of the future available for all.

Cellcolabs builds on the findings and clinical experience from more than 20 years of stem cell research at Karolinska Institute. World renowned stem cell professor Katarina Le Blanc with research group has published 167 scientific papers with 30 000 citations (as of 2021), resulting in exceptional MSC quality. The MSC are derived from bone marrow and have been approved by Swedish Medical Product Agency (MPA) for use in two academic clinical trials in Sweden, with more clinical trials planned internationally.

Cellcolabs provides both research and GMP grade MSCs to a variety of clients, including biopharma companies, hospitals, clinics, as well as companies using MSC for other purposes.


Visit Website


Visit Website
Cellex Cell Professionals – your CDMO in Europe
Cellex supports biopharma and academia with a full portfolio of services around cell and gene therapy for research, clinical and commercial use worldwide.

Our company has experience in development of cGMP processes, GMP manufacturing of autologous and allogeneic cell therapy products using vectors and LNPs, quality control testing and release.

In our state-of-the-art GMP facility cellular subsets can be separated and frozen but also genetically modified and analyzed. All processes are adapted to the customers' needs, based on profound experience with EU and FDA regulations.

Cellex also stands for a successful tech transfer of processes from US to Europe.
Our apheresis centers have all techniques for collection of different starting materials from healthy donors. Cellex runs its own highly diverse donor pool and offers leukopak, bone marrow or whole blood products customized for R&D, clinical or commercial purposes.

IT and transport solutions complete the Cellex portfolio.


Visit Website

Home | Cellectis

Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes an allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to make therapeutic gene editing in hemopoietic stem cells for various diseases. As a clinical-stage biopharmaceutical company with over 23 years of experience and expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to treat diseases with unmet medical needs. Cellectis’ headquarters are in Paris, France, with locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS).    



Visit Website

Sartorius CellGenix is a leading global supplier of high quality raw materials for the expanding cell and gene therapy and regenerative medicine space. We develop, manufacture and market human cytokines and growth factors along with GMP serum-free media. To allow for a seamless transition from preclinical development to the clinical stage we offer our human cytokines and growth factors in preclinical and GMP quality. Our products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world.

With 25 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space. As a former ATMP developer and manufacturer we gained in-depth cell culture knowledge and superior regulatory expertise. With this unique background we understand the high requirements our customers face during product development and the regulatory approval process. By offering expert technical and regulatory support we can help simplify raw material qualification and validation efforts.

Sartorius CellGenix operates a state-of-the-art GMP facility for production of recombinant proteins and cell processing in Freiburg, Germany. A subsidiary is located near Boston in Portsmouth, NH/USA.
Safe │ GMP Compliant │Reliable


Visit Website
Cellexus is a Scottish company, manufacturing unique, airlift, single-use bioreactors. The CellMaker systems have working volumes from 1.5L to 50L yet the system has a small footprint for use in laboratories and clean rooms. The CellMaker Low Flow is optimized for mammalian cells to further reduce shear forces on cells which happen in an impeller system. Efficient and gentle mixing is purely by air in the CellMaker so there are no moving parts. This has the added benefit of easy maintenance. The single use, GMP compliant CellMaker is ideal for raw material production (viral vectors and cytokines), process development and GMP manufacturing of advanced therapies.

Visit Website

Cellular Highways, a TTP company, is developing a new generation of automated high-throughput, scalable cell sorting instruments for research, diagnostic and therapeutic applications.

Powered by VACS, a new microfluidic cell sorter technology, our instruments will reduce the cost and complexity of cell sorting and achieve far higher throughput than existing platforms, thus making cell sorting accessible to every laboratory as well as enabling new clinical applications.

Our first product, Highway1 is designed for sterile, GMP compatible therapeutic cell sorting. Highway1 is now a beta prototype, and we are looking for testers with challenging needs. Please get in touch if you would like to be a beta tester!



Visit Website
About Cellular Origins
Cellular Origins, a TTP Company, is focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies.
Despite the incredible potential for cell and gene therapies in the treatment of disease, emerging therapies are inaccessible to patients due to insufficient expertise and manufacturing capability for affordable production. With an increasing number of approved cell and gene therapies currently reaching the market, the disconnect between innovative therapies and manufacturing capabilities has led to an urgent need for solutions that provide large-scale access to cost-effective, next-generation therapeutics.
Created to provide therapeutic developers access to the equipment they want, at the scale they need, Cellular Origins’ proprietary technology provides a transformative solution for automated, sterile, fluidic interconnection, to enable cell and gene therapy manufacturing at scale. Cellular Origins technology has been carefully designed to integrate into existing workflows, alleviating the need for process redevelopment, without constraining process innovation.
TTP has more than 30 years’ experience in supporting the world’s most innovative and ambitious organisations develop new tools and technologies, from creating the first highly scaled out roller bottle manufacturing platform for Amgen to creating new bioprocess tools companies such as TAP Biosystems. Bringing together expertise from across the life science, engineering, and robotics industries, Cellular Origins is focused on enabling developers to accelerate their therapeutics to market.
To find out more about Cellular Origins and its innovative cell therapy manufacture solutions, please visit https://cellularorigins.com/. Follow Cellular Origins on Twitter (@CellularOrigins) and LinkedIn (@CellularOrigins)


Visit Website

Center for Breakthrough Medicines (CBM) is an Advanced Therapy CDMO dedicated to addressing the challenges with bringing breakthrough therapies to patients. CBM offers pre-clinical through commercial manufacturing capabilities spanning process development; plasmid DNA, viral vector, and cell therapy production; and a full suite of testing and analytical capabilities. Through a single-source, end-to-end solution, CBM accelerates time to market without compromising quality.


Visit Website

At Charles River our focus is always on anticipating tomorrow’s drug development needs today and this is why we have invested in the tools, talent and capacity to further the new frontier of cell and gene therapy development. We can support your cell and gene therapy programs every step of the way, from early discovery, manufacturing of viral vectors, plasmid and autologous/allogenic cells, toxicity/toxicology studies, to analytical release testing of your cell line characterization, biosafety and potency testing. Our global footprint, team of experienced professionals and unsurpassed portfolio of integrated services are dedicated to supporting you to help get your product to patients faster. To learn how we can help accelerate your cell and gene therapy goals, visit criver.com/CGT.


Visit Website
Exclusively dedicated to Life Science and Biodiversity, Cryo Bio System strives to provide scientists and physicians with the groups’ expertise in the field of cryopreservation of biological samples, with innovative and High Security products. With 30 years of experience, Cryo Bio System is today recognized internationally for the quality of its products. Our complete range of products intended for human application allows the freezing at very low temperature of any biological sample whatever its physical state. Our unique high-security concept for long-term cryopreservation guarantees unsurpassed security and storage quality.


Visit Website
Cryoport Systems is a market leader in globally integrated temperature-controlled supply chain support for critical, irreplaceable products and materials in the life sciences industry. We are already trusted to support over 600 active clinical trials and leading commercial products worldwide - delivering unparalleled, integrated supply chain services for products, therapies and treatments requiring unique, specialized temperature-controlled management. And, as the life sciences constantly evolve and advance, so do we.


Visit Website

The Curate® Cell Processing System gently isolates leukocytes using Deterministic Cell Separation™ (DCS), an advanced, highspeed microfluidic technology that gently separates cells based on size. Optimized for processing apheresis and cell culture samples, the Curate obtains uniquely larger quantities of healthier leukocytes compared to other separation technologies.



Visit Website

Digi-Trax® is the recognized leader in providing ISBT bar code compliance labeling software, hardware and supplies to healthcare. Our HemaTrax®-CT (cellular therapy) and HemaTrax® blood labeling systems are successfully operating in thousands of facilities worldwide. Our product line includes labels, printers, both mobile and desktop, scanners, ribbons and even temperature indicators and mounting accessories. With more than 30 years of experience, we have developed the optimal identification solutions for all blood and cellular therapy labeling applications. Our labels are designed for the rigorous environment in which you work. Rest assured, our cellular therapy labels will perform just as required on your cellular therapy products. We follow all FACT and ICCBBA guidelines within our HemaTrax-CT software so you can feel confident that your facility is ISBT 128 compliant. We also offer a yearly software maintenance program so that all updates and changes to these guidelines will be available for you to download. We proudly enhance our product and service offerings with complete technical service and support. Our manufacturer certified technicians can troubleshoot over the phone and resolve any situation you may encounter. Rely on Digi-Trax for your cellular therapy and blood bank identification needs. Contact us for more information today at (800) 356-6126 or www.digi-trax.com.



Visit Website
Ecolab’s Life Sciences division is dedicated to developing the best possible products and services to support our customers in the pharmaceutical industry. Our comprehensive solutions and technical expertise are focused on cleaning, sanitisation and contamination control, all while ensuring safety, compliance and operational efficiency. Our strategy is to stay focused on two core areas: Global Trends and Regulatory Changes that impact your operations, and develop solutions to keep you on the cutting edge.



Visit Website

Entegris has more than 50 years of proven materials science experience in the world’s most demanding industries. Entegris’ flexible high-purity manufacturing and technical expertise deliver tailored solutions in cell and gene therapy (CGT) workflows. The unique combination present within Entegris’ Aramus product line of lower particulate, and superior performance in cryogenic (-196C) workflows provides many benefits in CGT processing, storage and transport. Furthermore, the capability to provide configured cell expansion and harvest solutions including Entegris’ easy to use economic microcarrier separation system along with the freeze thaw (F/T) technology center for optimization of FT workflows has enabled our clients to save hundreds of operator hours annually and achieve many of their commercialization goals on time or early.

Visit Website

coming soon



Visit Website




Visit Website

Établissement français du sang — Wikipédia

Etablissement Français du Sang (EFS) is offering a full range of services to make ATMPs accessible to patients for highly unmet medical needs. Based on our 4 pharmaceutical ATMPs production platforms all over France, EFS is equipped with 16 GMP class B-rooms. EFS is fully linked with researchers and clinicians during the entire process. EFS expertise provides you with a real support on development stages, scaling up and GMP manufacturing for your preclinical and clinical batches. EFS helps yourselves on a multiple cells types such as MSC, CAR-T, iPS, hESC and HSC. Of course, we also work to assure quality controls management.





Visit Website

Excellos is a unique full-service CDMO that pairs the collection of critical human cells and tissues with manufacturing and development services to drive innovation in the cell and gene therapy industry. Built on the foundation of the San Diego Blood Bank, with over 70 years of experience in blood and tissue collection and handling, Excellos is focused on supplying cGMP cellular products and services, together with process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies.



Visit Website


Visit Website
Flash Therapeutics is a CDMO expert in lentiviral vectors manufacturing, developing RNA & DNA carriers for therapeutic applications.

Flash Therapeutics develops and produces gene based therapies leveraging its proprietary lentiviral production platform through two business lines: gene transfer delivery biotechnologies design (RNA and DNA) and development and manufacturing support to companies worldwide pursuing lentiviral-based projects from R&D to clinical applications.

Depending on the customers’ application, Flash Therapeutics provides integrative lentiviral particles or LentiFlash®, a biological RNA technology based on a lentiviral particle. Both technologies benefit from novel production and purification processes developed and continually optimized since 2005.




Visit Website

Visit Website
G-CON - BIO International Convention | BIO
G-CON builds PODular cleanrooms offsite for innovative biopharmaceutical companies. Streamlined, offsite building processes enable G-CON to deliver the highest quality cleanroom facilities, quickly and on time. G-CON adapts to unique requirements on every build, delivering projects with our commitment to certainty every time.


Visit Website

Genesis BPS is a global manufacturer and supplier of precision equipment to clinical laboratories, life science customers, blood collection and cellular therapy organizations. Our product portfolio represents quality and consistency in a world of ever-changing requirements for processing, collection and storage.
Visit our booth to learn more about our tools for science including Dry Thawing Devices, Waferless Sterile Tube Welder’s, Tube Sealers, Collection Devices, Therapeutic Phlebotomy products, specialty blood bags and a whole lot more.
To learn more visit genesisbps.com or call one of our representatives at 866-71-BLOOD. Genesis BPS...Technology is in our blood!

Visit Website

GenScript Biotech - Wikipedia

GenScript Biotech Company is a leading global biotech company that provides a wide range of life science research tools and services to help accelerate the discovery and development of new drugs and treatments. The company was founded in 2002 and has since grown to become a trusted partner to researchers, pharmaceutical companies, and biotechnology startups around the world. GenScript offers a comprehensive suite of services, including gene synthesis, custom protein production, and antibody services, as well as a wide range of research tools and reagents, such as CRISPR-Cas9 gene editing systems, viral vectors, and more. These services and products are designed to help researchers streamline their work, reduce costs, and increase the speed and accuracy of their research. At the heart of GenScript's success is its commitment to quality and innovation. The company employs a team of highly trained scientists and engineers who are dedicated to delivering cutting-edge solutions to the life science community. With advanced technologies, world-class facilities, and a rigorous quality control process, GenScript is well positioned to help researchers achieve their goals. In addition to its services and products, GenScript also offers a range of educational and training programs to help researchers and students stay up-to-date with the latest developments in their field. The company also provides a range of resources and support to help researchers overcome challenges and achieve their goals, including a knowledgeable customer support team, access to cutting-edge tools and techniques, and a community of like-minded researchers and innovators. Overall, GenScript Biotech Company is a trusted partner to the life science community, providing a wide range of services, products, and support to help researchers and companies advance their work and make a positive impact on the world. Whether you're working on a new drug discovery, developing new treatments for diseases, or exploring new avenues of scientific research, GenScript has the expertise and resources you need to succeed.






Visit Website

End-to-End CDMO Service - GenScript ProBio

GenScript ProBio, a subsidiary of GenScript Biotech Corporation, offers end-to-end CDMO services from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in CGT, vaccine, biologics discovery and antibody protein drug, aiming to accelerate drug development for customers. GenScript ProBio has established companies in the United States, the Netherlands, South Korea, and China (Hong Kong, Shanghai, and Nanjing) and other regions to serve global customers, and has helped customers in the United States, Europe, Asia Pacific and other regions obtain more than 40 IND approvals since October 2017. GenScript ProBio’s total CGT solution covers CMC of plasmid and virus for IND filing as well as clinical manufacturing and commercial manufacturing. GenScript ProBio’s innovative solutions for biologics discovery and development include therapeutic antibody discovery, antibody engineering and antibody characterization. In the biologics CDMO service, GenScript ProBio has built a DNA to GMP material platform, including stable cell line development, host cell commercial license, process development, analytical development to clinical and commercial manufacturing, and offer fed-batch and perfusion processes to meet the growing needs for antibody and protein drugs. GenScript ProBio has established GMP capacity that meets regulatory requirements of the US Food and Drug Administration (FDA), European Medicines Agency (EMA) and National Medical Products Administration (NMPA). Toward the mission of “Innovation through Collaboration”, GenScript ProBio is committed to helping customers shorten the timeline for the development of biological drugs from discovery to commercialization, significantly lowering R&D costs and shaping a healthier future
Halo Labs knows aggregates and particles. The Aura can count and characterize subvisible particles and tell you if they are aggregated drug product, excipients, or external contaminants. A simple, plate-based approach enables low-volume, high-throughput, fully automated particle imaging and analysis at any stage from developability assessment through quality control.




Visit Website
Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise.
The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production.



Visit Website
JPT Peptide Technologies is a global provider of quality, state of the art peptide tools for cell based therapies and assays for immunology and cellular immunotherapy. These include our antigen-spanning overlapping peptide pools, PepMix™ Peptide Pools, for T cell assays and epitope discovery, our clinical grade peptide (CGP) for immunotherapy approaches including Adoptive Cell Transfer, peptide therapeutics, pulsing of Dendritic Cells and cellular immune monitoring as well as our PepStar™ Peptide Microarrays for seromarker discovery and humoral immune monitoring. These tools are available as off-the-shelf products, as well as fully customizable solutions for your specific needs. With decades of experience in synthetic peptide synthesis, and a proven track-record of providing market-leading, superior quality peptide tools for clinical applications, we can partner with you to advance your therapies. Please visit our booth, or contact us directly during the conference to discuss your needs! You can write US-BD@jpt.com.



Visit Website
MAK-SYSTEM - ePROGESA is an advanced Management Software
Since 1984, MAK-SYSTEM is a market leader in the digitalization of the transfusion medicine and a key player in the Tissue & Cell Therapy domain. With our experience, we can deliver Value Based Healthcare to our clients which are already located in more than 30 countries.

We create and deliver the innovative technologies that are used to ensure the efficiency, compliance, and safety of the global supply of blood, plasma, and cellular products. 





Visit Website

Visit Website

Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene therapies. We offer our clients high value clinical and commercial manufacturing services, development solutions, and technologies. We are pioneers in the field with more than 20 years’ experience providing outstanding quality and reliability. Our facilities in North America, Europe, and Asia allow us to supply patients worldwide with life-changing therapies.


Visit Website

Mirus Bio | The Transfection Experts

Mirus Bio revolutionized transfection over 25 years ago with the introduction of its flagship product, TransIT®-LT1. Pioneering new delivery solutions, such as TransIT-X2®, Mirus is a critical supplier of novel transfection reagents. With the introduction of TransIT-VirusGEN®, Mirus expanded expertise to virus manufacturing, supporting researchers from discovery to clinic.


Visit Website


Visit Website

One and Two Discovery Square are the epicenter of what’s next in healthcare. Here, visionary start-ups, researchers, educators and companies collaborate with the esteemed Mayo Clinic and one another to advance biomedical technology and treatments of tomorrow.
When you locate at One or Two Discovery Square, you will be in the heart of Destination Medical Center’s Discovery Square District. Destination Medical Center is a 20-year, $5.6 billion economic development engine creating a global destination for health and wellness with Mayo Clinic and innovation at its core. You will be steps from Mayo Clinic’s 1.5 million square feet of research and lab space, with access to Mayo Clinic core services and Mayo Clinic Ventures, which can help advance your intellectual property and business.
Designed for collaboration, One and Two Discovery Square are state-of-the-art buildings thoughtfully designed to fuel collective energy, creativity and problem-solving, and expedite the time from bench to bedside. Onsite programming fosters interaction and moments of structured serendipity among tenants and researchers, physicians and business leaders from the greater Rochester community.


Visit Website

MVE Biological Solutions
MVE Biological Solutions is the leading global manufacturer of vacuum insulated products and cryogenic systems. Over 50 years, we set the standard for storage of biological materials at low temperatures. MVE is the preferred brand for cryogenic equipment in a variety of application areas including bio-pharma cell and gene therapies, storage of cord blood and stem cells, medical research facilities, government institutions, IVF centers, hospitals and clinics, and animal husbandry and livestock.


Visit Website
Myriade develops the VIDEODROP, an innovative nanoscale imaging technology.

Based on the principles of interferometry, the Videodrop makes it possible to measure the size and concentration of biological nanoparticles like lentivirus, adenovirus or retrovirus
• in real time (40s)
• in a single drop (5µL)
• between 80nm & 500 nm
• in a concentration range of 10E8 to 10E10 part/ml
• without labelling & no purification
• on viscous & complex samples

Videodrop measures the physical titer of viral vector solutions, so it allows to:
• Continuously monitor bioproduction processes thanks to its rapidity of measurement (40s)
• Work on real samples at any stage of the bioproduction in a non-denaturant way
• Control the yield of vector production after harvesting, Purification, or Concentration steps
• Quickly identify lot-to-lot variations

Providing linear results compared to p24 ELISA, VIDEODROP is suitable for "at-line" characterization of lentiviral vectors and in-process controls.


Visit Website

New at Bartelt: NanoEntek - Bartelt: Onlineshop für Laborbedarf – Graz, Steiermark, Österreich

From the start till today, NanoEnTek aims to develop innovative and easy to use products for life science research and help life science researchers consume their time and passion for discovery, instead of repetitive and tedious work. Although NanoEnTek has grown to the company with 150 employees now, global market leader is not an objective to NanoEnTek. NanoEnTek always keeps our initial mission in mind and help researchers contribute for the better world.
Store - Nanotein
Nanotein Technologies, Inc. is a Berkeley-based biotech startup company that makes next-generation Cell Therapy reagents. Nanotein recently launched their advanced T-cell technology that can enhance the efficacy of T-cell therapies by stimulating the expansion of stem cell memory T cells with self-renewing and multipotent qualities during ex vivo expansion.




Visit Website

NecstGen is a centre of excellence for Cell and Gene Therapy, located in a purpose-built GMP facility on the largest bio-cluster in the Netherlands, Leiden Bio Science Park. Here, NecstGen provides critical contract development, manufacturing, and rental services to academic and industrial therapy developers to deliver a new generation of therapies to patients.

NecstGen offers:
Full contract manufacturing services for Cell Therapy and Viral Vector;
Process design, scale-up, optimization and automation for Cell Therapy and Viral Vector;
Assay development for in-process, release, and potency;
Cleanroom rental including services for QA, QC, and QP.


Visit Website
Newcells builds functionally relevant in vitro models that accurately predict in vivo outcomes. Globally recognised scientific expertise and innovation is embedded in all it’s products and services.

Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we engineer models of kidney, retina, liver and lung from patient samples as well as from a range of preclinical species.


Visit Website
NHS Blood & Transplant is dedicated to saving and improving lives. Our Cellular, Apheresis and Gene Therapy division does this by supporting the development and delivery of innovative and advanced medicines. Principal within the division is the Cellular and Molecular Therapies (CMT) function offering experience and expertise in the manufacture of cell and gene therapies through our national network of GMP-grade and MHRA-licensed facilities. From January 2023, the Clinical Biotechnology Centre (CBC), part of CMT, will be fully operational from a new purpose-built facility. This will provide increased capacity for GMP plasmid, viral vector (AAV and lentiviral) and recombinant protein manufacturing. CBC was awarded a £4.9m grant by MRC/LifeArc to create one of three Gene Therapy Innovation Hubs to accelerate academic-led development of novel gene therapies throughout the UK. Operating on a ‘not for profit’ basis, NHSBT partners with academic, commercial and NHS organisations engaged in novel cell and gene therapy programmes, supporting concepts through to clinical trials. We welcome expressions of interest for contract projects, partnerships and joint grant proposals with organisations striving to develop the future of medicine in the advanced therapies space.


Visit Website
Nordmark Pharma GmbH
Nordmark, one of the world's largest manufacturers of pharmaceutical collagenase, produces high quality enzymes with the regulatory support necessary for the clinical environment. Our Collagenase NB 6 GMP Grade is a fast and reliable tool for stem cell isolation from adipose tissue, proven effective by a variety of customers over many years. We also offer highly-purified, animal-free Collagenase AF-1 GMP Grade and Neutral Protease AF GMP Grade as excellent alternatives for cell isolation.




Visit Website

NorthX Biologics ('NorthX') provides process development and manufacturing services with expertise in plasmids, proteins and other advanced biologics. NorthX Biologics sits in the heart of Sweden, and our team has been manufacturing biologics to GMP since 1988. In 2021 we were recognized as a national innovation hub for advanced therapeutics and vaccines.



Visit Website
OrganaBio is a robust and reliable biotech solutions provider for cell therapy and immunotherapy developers. OrganaBio has opened doors to a new CTDMO paradigm with a passionate commitment to ethically accelerate the deployment of cell therapies through making accessible critical resources that are essential for therapeutics development. The company’s products and services span the full development lifecycle – from proprietary blood and tissue supply chains and cellular starting materials (e.g. MSCs, HSCs, NK cells, T cells, etc.) to expert development, testing, and other support services that expedite the path to clinical translation within our state-of-the-art, ready-to-use cGMP manufacturing facility, enabling the rapid and economical manufacture of clinical materials.


Visit Website
OriGen Biomedical supplies a complete line of single use disposable products for use in Regenerative Medicine applications including T-Cell therapies. Our products are FDA-cleared, MDSAP-certified, CE-marked, cGMP-manufactured, and ISO 13485:2016 certified.

The PermaLife Cell Culture Bag is an optimal way to protect critical cell cultures. PermaLife has a user-inspired design including a needle-free, luer-actuated adapter which is self-sealing to make it easy to sample, feed, and harvest sensitive cells. The PermaLife is also gas permeable and water impermeable which eliminates the need for a humidified incubator.

The CryoStore™ Freezing Bag is the industry-preferred cryogenic freezing bag. The CryoStore™ Bag is available in a variety of configurations including a number of tubing and multi-bag options, allowing you to select the product that best fits your process.

The CryoStore™ Multi-Chamber Freezing Bag allows for cryopreservation of small volume blood components for future regenerative medicine applications. Multiple chambers are filled simultaneously through the channel at the bottom of the bag. The individual 4-6mL chambers allows for multiple post thaw applications.

CryoPur™ DMSO Solutions are certified to USP and Ph. Eur. Standards. CryoPur, CryoPur-D, CryoPur-S, and CryoPur-T Solutions come sterile, aseptic filtered and are non-pyrogenic. CryoPur™ Solutions are available as 100% DMSO and a DMSO Dextran mixture. OriGen supplies CryoPur™ in vials and syringes to meet your organization’s needs.

OriGen is known for its customer-driven product development process where OriGen can adapt its products to better fit laboratories’ protocols, not force labs to change protocols to match OriGen’s products. Visit https://www.origen.com/customer-driven-product-development-process for more information.


Visit Website


Visit Website

PBS Biotech aims to be the leading provider of innovative, single-use bioreactor systems specifically designed to address the unique challenges of cultivating shear sensitive cell types for use in allogeneic cell therapy. Our offering includes scalable, cost-effective disposable solutions designed to take you from benchtop R&D to large-scale cGMP manufacturing, and expert process development services to help solve cell culture challenges and accelerate the path to commercialization.
To learn more, contact our sales team at sales@pbsbiotech.com or visit our website at www.pbsbiotech.com.


Visit Website
Peli BioThermal is the first cold chain packaging solutions provider to make available a broad and comprehensive portfolio of patented and award-winning single-use and reusable thermal protection packaging solutions for the safe transport of pharmaceuticals, clinical trials, diagnostics, cell & gene therapies, tissue, vaccines and blood supplies for the life science industry.
Collaboration with our clients is the first step to ensure we provide a solution that is built around the unique and very specific needs of your temperature-sensitive payloads. Our global services network provides consultation, support, engineering and deployment for your cold chain distribution challenges wherever they exist.
Peli BioThermal designs products to ensure our customers valuable payloads are kept in perfect condition, irrespective of external temperatures and conditions. They are designed to be strong and robust, to survive the rigors of international transport. With environmental issues in mind, we ensure that our design team specify the correct materials and consider ‘end of life’ recycling for all of our ranges, whether they are single use or reusable packaging systems.



Visit Website
PeproTech is a business unit within the Thermo Fisher Scientific Biosciences Division, specializing in manufacturing high quality cytokine products and providing exceptional service to the global life science and cell therapy markets. Our products include Recombinant Human, Murine and Rat Cytokines, Animal-Free Recombinant Cytokines, GMP Cytokines, Antibodies and ELISA Kits.

Our mission is to provide the highest quality products and premium support that address the needs and demands of today's scientists and researchers.

We pride ourselves on being a trusted partner within the scientific community.
Please contact PeproTech to request a quote or discuss your research requirements:
Tel: 020 7610 3062 or Email: PeproTech.Info@thermofisher.com


Visit Website


Visit Website

Together, we are making a difference for the better.
Last year, 35 million babies in over 90 countries were screened using PerkinElmer tests, saving the lives of more than 70 babies each day on average.
To date, more than 650 million babies have been tested for life-threatening diseases using
PerkinElmer’s newborn screening tools.
220 million tons of wheat are analyzed for quality each year by PerkinElmer instruments. Our
technologies can also detect food fraud in under 30 seconds.
PerkinElmer instruments test 289 billion gallons of water annually, to provide safe drinking water for more than 1 billion people, and help reduce 8 million metric tons of plastic waste from our oceans.
PerkinElmer’s EUROIMMUN business created the first commercially available serological test to detect Zika virus.
Around the world today, more than 2 million scientists are using PerkinElmer’s laboratory software to store and analyze research data and collaborate on experiments.
PerkinElmer technologies have contributed to the development of 22 novel therapeutic drugs.





Visit Website

Precision NanoSystems is a global leader in ushering in the next wave of genomic medicines in infectious diseases, cancer, and rare diseases. We work with the world’s leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine. Precision NanoSystems offers proprietary technology platforms and comprehensive expertise to enable researchers to translate disease biology insights into non-viral genomic medicines.



Visit Website

QIAGEN pushes the boundaries of innovation to improve our understanding of DNA, RNA and proteins – the building blocks of life. We enable our customers to unlock valuable insights from any biological sample – be it blood, a throat swab or many other materials. We support their success with a broad range of products for molecular testing, serving applications from basic life sciences research to clinical healthcare. Never before have QIAGEN’s molecular testing solutions made a stronger impact on people’s lives than in the global fight against COVID-19. It is one of the many ways we are¬ advancing science and improving outcomes for people across the world. We are known for highest quality products and outstanding service from a global organization of 6.000 passionate people in 35 countries. Our reputation is based on confidence in decisions, clarity of results and pride in the insights our customers achieve. More than 35 Nobel Prize winners among more than 500,000 customers worldwide are proof of that success. We will continue to define the advancements of tomorrow – in line with our vision of making improvements in life possible.

Visit Website

Since 1982, Rees Scientific has been the most compliant continuous environmental monitoring system in the industry. Our system can monitor the temperature of any cold storage (refrigerators, freezers, ultra-low freezers) from +1300 to -196 °C. We monitor equipment and parameters such as temperature, humidity, light, differential pressure and more. We can help protect critical assets in cell therapy, stem cells and regenerative medicine. As an ISO 9001 credited and 17025 accredited company, we can help meet regulatory requirements for FDA, GxP, 21CFR part 11, and more. Receive alarm notifications via interactive telephone, emails and texts. Rees Scientific’s monitoring system is easily expandable to fit every customer’s needs, large or small. It can be installed on your network or on the ReesCloud. Our regional sales, service and engineering team can partner with you to implement the best system according to your requirements.



Visit Website

REPROCELL's corporate vision is to promote human health by providing cutting-edge research products, services, and partnerships that advance the future of Regenerative Medicine. At REPROCELL, we manufacture custom GMP iPSC – Master Cell Banks (MCB) compliant with the regulatory standards and guidelines of the FDA, EMA, and PMDA. The Seed Clones for MCB generation are made with our 4th Generation mRNA reprogramming technology. We have a bank of Seed Clones available for the Sponsor to evaluate before MCB generation, or we can prepare a Seed Clone bank specifically to meet the Sponsor's specifications. For drug discovery, REPROCELL’s pre-clinical contract research organization is an experienced partner uniquely positioned to provide custom assay services using live human tissues or 3D tissue models. Our Central Laboratory Services offer a range of operational capabilities to accelerate drug development programs and support global clinical trial needs. From routine peripheral blood mononuclear cell (PBMC) processing to more complex genomic, proteomic, and cellular analyses, we deliver consistent quality-controlled sample handling and processing services to meet the demanding needs of innovative clinical research. REPROCELL has expanded through a series of acquisitions over recent years creating a workflow including human tissue acquisition (BioServe®), RNA reprogramming (Stemgent®), 3D technologies (Alvetex®), and drug discovery (Biopta®) to the development of clinical stem cells. We can help with all areas of regenerative medicine preclinical development.


Visit Website
RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and extracellular vesicle (EV) product and process development to fuel the rapid commercialization of scalable advanced therapies. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and EV production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type 2 Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under 1 year. RoosterBio is driven by the client’s success and creating a world where safe and effective regenerative medicines are rapidly developed and widely available on a global scale.



Visit Website

RoweMed AG – Medical 4 Life is an innovative MedTech company. Our focus is on complex customized plastic-systems, especially for the handling of sensitive pharmaceuticals.


We realize "turnkey" projects for our customers, from the initial sketch to CAD design and rapid prototyping right through to an approved serial product. For our projects we offer the complete documentation.


In our certified clean rooms, we offer injection molding, assembly and packaging from a single source. This is how we realize high-efficiency individual processing, small series and automated large series.


Visit Website

Saint-Gobain Life Sciences is an industry leading provider of material science based solutions for single-use fluid management, including TPE and silicone tubing, connection and flow control components, bioprocess and cell culture bags, filtration products, sensors, and over-molded technology, all available in customized assemblies that are produced in 20 manufacturing facilities located around the world. 


Visit Website
High Quality Raw Materials for Cell & Gene Therapy
Sartorius CellGenix is a leading global supplier of high quality raw materials for the expanding cell and gene therapy and regenerative medicine space. We develop, manufacture and market human cytokines and growth factors along with GMP serum-free media. To allow for a seamless transition from preclinical development to the clinical stage we offer our human cytokines and growth factors in preclinical and GMP quality. Our products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world.

With +25 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space. As a former cell therapy developer and manufacturer we gained in-depth cell culture knowledge and superior regulatory expertise. With this unique background we understand the high requirements our customers face during product development and the regulatory approval process. By offering expert technical and regulatory support we can help simplify raw material qualification and validation efforts.

Sartorius CellGenix operates a state-of-the-art GMP facility for production of recombinant proteins and cell processing in Freiburg, Germany. We are now part of Sartorius.

Safe │ GMP Compliant │Reliable
 Freiburg, Germany. A subsidiary is located near Boston in Portsmouth, NH/USA. Safe │ GMP Compliant │Reliable


Visit Website

Sartorius is focused on providing its customers in the biopharmaceutical industry as well as at biotech start-ups and in science the tools and technologies to achieve such breakthroughs, enabling researchers, developers, and engineers to reach their goals faster and at lower costs.  We empower scientists and engineers to simplify and accelerate progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine.  We are a magnet and dynamic platform for pioneers and leading experts in our field. We bring creative minds together for a common goal: technological breakthroughs that lead to better health for more people.

In 2021, sales revenue rose to around €3.45billion, not only due to our contributions in producing newly developed coronavirus vaccines and test kits at an unparalleled speed and in unprecedented quantities. Our core business generated even higher contributions to our growth, achieving new record highs in all product segments, and in all geographies. At the close of 2021, Sartorius was proud to be working alongside almost 14,000 global employees. Investments totalled around €400million and were used to expand our capacities in several product segments and in all business regions.


Visit Website
The SCINUS Cell Expansion system is a closed bioreactor system for the controlled cultivation of cells, supporting R&D as well
as GMP processes. Combined with either the single-use Adherent or Suspension Bag it provides a scalable system for large-fold
expansion. The temperature-controlled hardware enclosure houses the Single-use Bags on a unique rocking platform that provides
an optimally homogenized culture environment with minimal shear stresses. The platform enables true scaling in culture volume, t
hanks to a unique roller/clamp system, allowing culture from minimal to clinically relevant amounts in one system. The system
operates stand-alone with a touchscreen interface, and is compatible with industry-standard controller software for process control,
monitoring and data acquisition.
The system contains a single use bioreactor bag that can be used to cultivate adherent cells (e.g. human mesenchymal stromal cells),
as well as suspension cells (e.g. T-cells, NK cells) to clinically relevant numbers. Cells are grown in a single use, expandable bioreactor b
ag with continuous pH and dissolved oxygen control, which provides an optimized environment for growing cells and the closed
system minimizes the risk of contamination. Both bags can be used with the same Scinus Cell Expansion system configuration.
We also have several projects in which we work with iPSC’s. For an illustrative animation, please check our website (www.scinus.com).


Visit Website

SCTbio is a European global contract development and manufacturing organization for Advanced Therapy Medicinal Products (ATMPs). Founded in July 2021 as a spin-off from SOTIO, member of PPF Group, to directly address the growing demand for cell and gene therapy manufacturing, SCTbio holds over a decade of experience developing best-in-class clinical manufacturing services, development solutions and technologies transfers.


Visit Website
ASGCT 26th Annual Meeting
Our global network of experts will support you and your products at every stage, helping you deliver safe, effective and compliant medicines to your target consumers.




Since its establishment in 2000, Shanghai Model Organisms Center Inc. (SMOC) has built a rigorous and professional technical team with mature technology and complete processes. We have built more than 10,000 genetically engineered animal models, which can provide model customization services such as gene knockout, knockin, and transgenic overexpression. SMOC currently provides more than 6000 research-ready models, we have developed about 12000 genetically modified mouse strains and every year our R&D program has the capacity to create and produce more than 4000 strains. Our models are widely used in metabolic and cardiovascular disease, neurodegeneration, immunology, and oncology studies. We also provide all kinds of downstream services, such as drug screening and efficacy evaluation, etc. Our vision is to provide global researchers with professional, comprehensive and integrated animal model services.


Visit Website
SINFONIA TECHNOLOGY is a manufacturer of CellQualia* Intelligent Cell Processing (ICP) System for automatization of cell manufacturing based on our technological strength for of aerospace parts, electronic equipment, factory automation system, and motion control equipment. Basic concept of the system is to realize QbD-based cell manufacturing with a variety of process analytical technologies and Cell and Gene Therapy (CGT) 4.0 with a data management platform. We will also have a capability for contract cell manufacturing at our laboratory in Kobe. In that sense, we are not only an instrument manufacturing company, but also solution provider for stakeholders in a field of CGT.

*CellQualia is the brand name for Sinfonia Technology’s products for regenerative medicine.


Visit Website

Smart MCs' vision is to revolutionise wasteful bioprocessing and enable the scaling-up of adherent cell cultivation by eliminating the need for microcarrier removal, thus streamlining the process and increasing efficiency and productivity. Smart MCs specialises in developing customised microcarriers tailored to each specific cell type and application. Our microcarriers enable efficient and streamlined cell culture while minimising cell loss, resulting in cost-effective and high-yield expansion of cells.



Visit Website

Stem Cell Network - BioTalent Canada

The Stem Cell Network (SCN) is a Canadian not-for-profit that supports stem cell and regenerative medicine research; training the next generation of highly qualified personnel; and knowledge mobilization and transfer of stem cell and regenerative medicine research. From the lab to the clinic, SCN’s goal is to power life-saving therapies and technologies through regenerative medicine research for the benefit of all. Created in 2001, with support from the Government of Canada, the Network has grown from a few dozen labs to more than 200 world-class research groups, supporting over 200 research projects and more than 25 clinical trials. Since its inception, over 20 biotech companies have been catalyzed or enhanced and more than 5,000 highly qualified personnel have been trained. In 2021, the Government of Canada demonstrated its continuing trust and support in SCN with an investment of $45 million for the 2022–2025 period.


Visit Website

STEMSOFT offers a full electronic solution designed to document all phases of patient care and product manufacturing to help save you time; comply with quality and accreditation requirements; and easily access a complete dataset for analysis.


Visit Website
Synthego is a leading provider of genome engineering solutions. Our flagship product, CRISPRevolution, is a portfolio of synthetic guide RNA designed for CRISPR genome editing and research. Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.


Visit Website
Takara Bio Europe is a wholly owned subsidiary of Takara Bio Inc., who develops, manufactures, and distributes a wide range of life science reagents.

Key products include SMART cDNA synthesis kits for a variety of samples and applications, including NGS, high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes)[CC1] , Cellartis stem cells and stem cell reagents, RT enzymes and SMART library construction kits, the innovative In-Fusion® cloning system, Guide-it gene editing tools, Tet-based inducible gene expression systems, and Living Colors® fluorescent proteins.

Takara Bio’s portfolio supports applications including NGS, gene discovery, regulation, and function studies, as well as genetic analysis, protein expression and purification, gene editing, stem cell studies, and plant and food research. For more information, visit www.takarabio.com.


Visit Website
Over 45 years of experience have made Technoflex an innovative firm, as well as a European leader in the design and manufacture of flexible bags and connectors for the pharmaceutical industry.
Our cutting-edge technology and internal R&D resources enable us to provide customized, reliable and easy-to-use solutions. Our proficiency in the pharmaceutical primary packaging of injectable drugs and cell culture, allows us to produce innovative containers matching strong acceptance quality limit (AQL) level within our ISO 7 (Class 10000) clean room. Technoflex has also developed a high capacity working with all kinds of flexible films, which may be subject to high thermal amplitudes and permeability.

As for cellular therapy, SafeCell® and Cryocell® are state-of-the-art bags delivering high value in the areas of: ex-vivo cell culture, development of cell therapy treatment, blood derivatives, cryopreservation of cord blood and stem cells, and organ preservation. SafeCell®, our range of FEP bags, developed with a specific leak-proof design, offers optimal traceability. Recently Technoflex has released a new primary packaging, Dual-Mix®, for the reconstitution of unstable molecules.

Technoflex’s flexible containers are compliant with the US & EU pharmacopoeias (EP 3.1.3 & EP 3.1.6, 21CFR 77.18.10, USP class V, FDA DMF #19057, DMF #032647 and Canada DMF #2007-070).


Visit Website
TFBS Bioscience Inc. was founded in 2016 as the first Taiwanese viral vector CDMO company. However, our executive team's roots run deeper, going back to the viral-associated research laboratory in the Development Center of Biotechnology (DCB), a leading life sciences research institute in Taiwan. Through our years of service, we have accumulated good reputation in many projects with the trust of the government and the industry.

Nowadays, with our expertise in viral vector manufacturing and advanced equipment in our state-of-the-art facility, we are pioneering entrepreneurship in order to achieve our mission.


Visit Website
Title21 Health Solutions delivers easy-to-use, flexible and integrated technology to support health sciences organizations achieve compliance, gain efficiencies and ensure high quality, ultimately, to support improvement in patient safety and care.


Visit Website
OCELLOS by TrakCel is a powerful, integrated cellular orchestration solution for the precise management, control and tracking of cell and gene therapy products, patient by patient. With the largest number of live deployments and supporting autologous, allogeneic and personalised cancer vaccine therapies, TrakCel is amongst the most experienced in the industry. Working closely with clients, TrakCel has built a deep understanding of the challenges faced by advanced therapy developers globally.

TrakCel SaaS solutions are built on the Salesforce platform and offer visibility, insight and scalability, streamlining the delivery of more therapies, to more patients at their most vulnerable.

Visit Website



Visit Website

TreeFrog Therapeutics is one of the rare cell therapy biotechs that leverages biophysics to overcome the major bottlenecks of the industry, introducing new standards in terms of scalability, cell quality, transplantation efficiency and safety/functionality of cell therapy products.
Headquartered in France, with offices and labs in the USA and Japan, TreeFrog Therapeutics is advancing a pipeline of therapeutics candidates in regenerative medicine and immuno-oncology based on a disruptive technology platform: C-Stem™. Aimed at making cell therapies accessible to millions of patients, the company is developing a best-in-class iPS-derived cell therapy for Parkinson’s disease (Phase I in 2025), and recently announced collaborations in NK cell therapies with Umoja Biopharma (USA) and GAIA Biomedicine (Japan).



Visit Website

Trince is a spin-off company from Ghent University dedicated to advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo. The company's LumiPore transfection platform, which is covered by a portfolio of pending patents, can be used to deliver a wide variety of effector molecules (e.g. nucleic acids or proteins) into virtually any cell type, including hard-to-transfect cells such as immune cells for cell therapies. The technology not only makes it easier to bring genetic material into cells in high-throughput. It also ensures that this is done in a gentle manner, maximizing the therapeutic quality of the final cell product.



Visit Website

ViruSure is an Austrian company specialising in the virus and prion safety testing of biopharmaceutical products, such as ATMPs. Our in vitro and in vivo facilities are certified to GLP/GMP standards to ensure a high standard for all our testing. Reflecting the quality of our biosafety testing services, our reports have been submitted and accepted by regulatory authorities worldwide. We work together closely with all our customers to develop the best testing strategy for their product. Our service portfolio includes: - Cell and Virus Banking - Cell and Virus Characterization - PCR (for detection of over 130 viruses and other pathogens) - Rapid Mycoplasma Testing by qPCR - Tumorigenicity & Oncogenicity Studies - Biodistribution Studies for ATMPs - Genetic stability - NGS (R&D) - Sanger Sequencing - Virus/prion clearance studies - GMP storage - TEM


Visit Website
West is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. We are guided by our core values of Passion for Customers, Leadership in Quality and One West team and these values underpin our purpose to improve patient’s lives. With nearly a century of experience, we work together with our customers to support patient health and fuel a brighter future with product innovation. West works by the side of customers from concept to patient to develop products that promote the efficiency, reliability and safety of the world’s pharmaceutical drug supply.


Visit Website

Xcell Therapeutics is a manufacturer of serum-free chemically defined media for the expansion of hMSCs. Media for exosomes and NK cells are currently under development.




http://xcell.co.kr/

X-Therma is headquartered in Richmond, part of the San Francisco Bay Area, with research centers in Richmond and Berkeley, and now has expanded to Austria in Europe. X-Therma pioneers ground-breaking cold chain technology via a convergent biopreservation platform, to advance Regenerative Medicine and make available safe and on-demand organs, engineered tissues, cell & gene therapies, vaccines, and beyond to patients in need. X-Therma’s technology could be a paradigm shift that makes worldwide organ sharing possible and eliminates organ waiting lists across the globe. X-Therma has been a selected Industrial User at the Lawrence Berkeley National Laboratory and received over $11M contracts and grant support from the U.S. Department of Defense, the National Science Foundation, and the California Institute for Regenerative Medicine. The company recently closed an oversubscribed Series A of $13M. The FDA has granted its proprietary organ preservation solution, XT-ViVo®, and TimeSeal® Organ Transport Device, Breakthrough Device status. This designation is granted to products that have the potential to offer more effective diagnosis or treatment of life-threatening diseases with an unmet medical need.


Visit Website
One of the largest CDMO in Europe, Yposkesi offers a full range of services in LV vectors and AAV cGMP manufacturing. Within its 50,000 ft2 (soon to be 100,000 ft2) facility, Yposkesi operates 4 manufacturing suites for bulk DS (up to 1,000 L) and fill & finish.


Visit Website